C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2026)

C4 Therapeutics' Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.1 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 14.77% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (down 14.77% YoY), while the FY2025 annual figure was 0.1, up 3.5% from the prior year.
• Asset Utilization Ratio was 0.1 for Q1 2026 at C4 Therapeutics, down from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q1 2025 to a low of 0.04 in Q2 2023.
• Historically, Asset Utilization Ratio has averaged 0.09 across 5 years, with a median of 0.09 in 2022.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio sank 58.14% in 2023, then soared 129.92% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.07 in 2022, then slipped by 16.05% to 0.06 in 2023, then soared by 67.61% to 0.1 in 2024, then rose by 17.37% to 0.12 in 2025, then slipped by 11.95% to 0.1 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.1 (Q1 2026), 0.12 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.